🖥️ Sibel Health secures FDA approval for ANNE One platform The FDA approval includes alarms and alerts, alongside a central station, and makes ANNE One align with the IEEE SDC 11073 standard. In addition to the approval, the company has secured $30m in new equity financing, led by existing investors Steele Foundation for Hope and Dräger Steele, which previously led Sibel’s Series B round, contributed an additional $20m, while medical and safety technology firm Dräger added $10m to its previous Series A investment. Sibel plans to use the funding to deploy its platform, which features advanced wearable sensors for wireless monitoring of vital signs in patients aged 12 and older. Read more online: https://lnkd.in/et7nqh-a 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter
翻译：